Amna Anees

2 mins read - September 23, 2024

The U.S. Food and Drug Administration (FDA) has approved the immunotherapy pembrolizumab (Keytruda) in combination with chemotherapy as an initial treatment for adults with metast...

Amna Anees

5 mins read - August 28, 2024

In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential game-...

Amna Anees

2 mins read - August 22, 2024

A new biomaterial researchers have developed called GAG-DP is making a significant advancement when it comes to mesothelioma treatment. This has the potential to revolutionize tis...

Amna Anees

2 mins read - October 9, 2023

A groundbreaking study led by researchers at The University of Texas at Austin introduces a novel drug that restores the effectiveness of immune cells in combating cancer. Pub...

Amna Anees

2 mins read - January 17, 2023

Cutting-edge artificial intelligence (AI) technology has the potential to revolutionize care for patients presenting with acute chest pain, according to a groundbreaking study publ...

Amna Anees

2 mins read - May 25, 2022

A groundbreaking study published in the journal Radiology unveils the potential of artificial intelligence (AI) in revolutionizing cancer risk assessment for pulmonary nodules dete...

Amna Anees

2 mins read - May 3, 2022

A recent study published in the journal Radiology has revealed a concerning association between emphysema detected through CT scans and a heightened risk of developing lung cancer....

Amna Anees

3 mins read - March 30, 2022

Researchers at the University of Colorado Anschutz Medical Campus, alongside international collaborators, have made a significant discovery regarding the origin of mesothelioma, a...

Amna Anees

3 mins read - March 4, 2022

Bioengineers at Rice University have achieved a remarkable feat: eliminating advanced-stage ovarian and colorectal cancer in mice in as little as six days using a groundbreaking t...

Amna Anees

3 mins read - February 14, 2022

A recent study, led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center, has revealed promising results in the treatment of platinum/tax...

Amna Anees

2 mins read - October 10, 2021

In the realm of mesothelioma treatment, immunotherapy emerges as a beacon of hope, with researchers striving to unravel its potential against this rare and aggressive disease. ...

Amna Anees

3 mins read - July 14, 2021

In a groundbreaking Phase II study, spearheaded by experts from The University of Texas MD Anderson Cancer Center, a formidable duo of drugs, atezolizumab, and bevacizumab, has em...